Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 10, Issue 5, Pages 726-731Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.8b00610
Keywords
Premature termination codon (PTC) readthrough; 2-aminothiazole-4-carboxamides; library screening; cell-based assay; nonsense mutations
Categories
Funding
- Canadian Cancer Society [704700]
- Genome BC [POC027]
- Mitacs Award [IT03752]
Ask authors/readers for more resources
Nonsense mutations introduce a premature termination codon (PTC) and are the underlying cause of multiple rare genetic diseases and cancers. Although certain aminoglycosides bind to eukaryotic ribosomes enabling incorporation of an amino acid at the PTC and formation of full-length protein, they are inefficient and toxic at therapeutic doses. Library screening in assays that measure readthrough at a PTC in the TP53 gene in human HDQ-P1 cells identified six novel 2-aminothiazole-4-carboxamide derivatives that potentiate the PTC readthrough (PTCR) efficiency of G418 when used in combination. The two most potent compounds incorporated a 4-indazole motif on the 2-aminothiazole nitrogen and a hydrophobic aryl substituent on the carboxamide nitrogen. These compounds are valuable tools to further investigate the therapeutic potential of aminoglycoside-induced PTCR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available